Trade

with

Regeneron Pharmaceuticals Inc
(NASDAQ: REGN)
AdChoices
384.46
+3.45
+0.91%
After Hours :
384.20
-0.26
-0.07%

Open

381.00

Previous Close

381.01

Volume (Avg)

1.03M (792.64k)

Day's Range

373.34-384.85

52Wk Range

257.69-384.85

Market Cap.

38.86B

Dividend Rate ( Yield )

-

Beta

0.97

Shares Outstanding

99.09M

P/E Ratio (EPS)

109.89 (3.52)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 2.10B

    • Net Income

    • 424.36M

    • Market Cap.

    • 38.86B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 15.86

    • PEG (Price/Earnings Growth) Ratio

    • 1.57

    • Beta

    • 0.97

    • Forward P/E

    • 32.79

    • Price/Sales

    • 17.18

    • Price/Book Value

    • 16.26

    • Price/Cash flow

    • 51.55

      • EBITDA

      • 801.00M

      • Return on Capital %

      • 13.58

      • Return on Equity %

      • 20.52

      • Return on Assets %

      • 13.58

      • Book Value/Share

      • 23.44

      • Shares Outstanding

      • 99.09M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 389.40

        • Credit Rating

        • -

        • Analysts

        • 9

        • EPS Estimate

        • 7.15

        • Cashflow Estimate

        • 10.12

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 45.50

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -43.40

          • 17.04

          • Net Income

            Q/Q (last year)

          • 6.10

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 54.58

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 92.93

            • 82.75

            • Pre-Tax Margin

            • 32.10

            • 39.38

            • Net Profit Margin

            • 15.86

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 96.90

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -5.60

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -3.20

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.22

              • 0.76

              • Current Ratio

              • 5.46

              • 2.92

              • Quick Ratio

              • 4.87

              • 2.35

              • Interest Coverage

              • 18.75

              • 38.02

              • Leverage Ratio

              • 1.46

              • 2.21

              • Book Value/Share

              • 23.44

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 98.04

                • 277.78

                • P/E Ratio 5-Year High

                • 105.03

                • 634.30

                • P/E Ratio 5-Year Low

                • 4.27

                • 124.82

                • Price/Sales Ratio

                • 15.50

                • 9.35

                • Price/Book Value

                • 14.66

                • 8.50

                • Price/Cash Flow Ratio

                • 51.55

                • 50.25

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 20.52

                    (6.00)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • 13.58

                    (4.30)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • 17.54

                    (1.70)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • 169.35k

                  • 117.08k

                  • Inventory Turnover

                  • 1.61

                  • 1.48

                  • Asset Turnover

                  • 0.86

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  760.03M
                  Operating Margin
                  36.11
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  51.55
                  Ownership

                  Institutional Ownership

                  96.52%

                  Top 10 Institutions

                  60.97%

                  Mutual Fund Ownership

                  44.58%

                  Float

                  77.42%

                  5% / Insider Ownership

                  1.32%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • VA CollegeAmerica Growth Fund of America

                  •  

                    3,437,300

                  • -0.54

                  • 3.40

                  • Vanguard Health Care Fund

                  •  

                    2,795,500

                  • 60.34

                  • 2.75

                  • Fidelity® Growth Company Fund

                  •  

                    2,556,123

                  • -1.35

                  • 2.53

                  • VA CollegeAmerica New Perspective

                  •  

                    1,747,700

                  • 10.54

                  • 1.73

                  • Artisan Mid Cap Fund

                  •  

                    1,317,841

                  • -12.13

                  • 1.30

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,214,560

                  • 1.01

                  • 1.20

                  • iShares Nasdaq Biotechnology

                  •  

                    1,180,087

                  • -1.85

                  • 1.23

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    1,047,685

                  • 36.47

                  • 1.04

                  • JPMorgan Large Cap Growth

                  •  

                    820,900

                  • 5.76

                  • 0.81

                  • PowerShares QQQ

                  •  

                    810,705

                  • -1.08

                  • 0.85

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Sanofi

                  •  

                    22,535,558

                  • +1.49%

                  • 22.30

                  • Capital World Investors

                  •  

                    7,350,059

                  • -3.71%

                  • 7.24

                  • Wellington Management Company, LLP

                  •  

                    5,669,346

                  • +26.60%

                  • 5.58

                  • Fidelity Management and Research Company

                  •  

                    5,255,677

                  • -8.16%

                  • 5.18

                  • Sands Capital Management, LLC

                  •  

                    4,907,362

                  • +22.32%

                  • 4.83

                  • Vanguard Group, Inc.

                  •  

                    3,913,703

                  • -0.03%

                  • 3.85

                  • State Street Corp

                  •  

                    3,229,271

                  • -0.76%

                  • 3.18

                  • Artisan Partners Limited Partnership

                  •  

                    3,192,014

                  • -1.34%

                  • 3.14

                  • Viking Global Investors LP

                  •  

                    2,963,456

                  • +181.75%

                  • 2.92

                  • T. Rowe Price Associates, Inc.

                  •  

                    2,794,301

                  • -31.89%

                  • 2.75

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Speculative Growth

                  Style

                  Large Growth

                  Regeneron Pharmaceuticals Inc was incorporated in January 1988 in the State of New York. The Company is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of se...morerious medical conditions. The Company’s preclinical research programs are in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. Its manufacturing facilities are located in Rensselaer, New York and consist of three buildings totaling approximately 395,000 square feet of research, manufacturing, office, and warehouse space. It currently has approximately 54,000 liters of cell culture capacity at the...morese facilities. It faces competition from pharmaceutical, biotechnology, and chemical companies. Its competitors are Genentech, Novartis, Pfizer Inc., Bayer HealthCare, Onyx Pharmaceuticals, Inc., Eli Lilly and Company, Abbott, sanofi-aventis, Merck & Co., Amgen Inc., Roche, and others. Its present and future business would be subject to regulation under the United States Atomic Energy Act, the Clean Air Act, the Clean Water Act, the Comprehensive Environmental Response, Compensation and Liability Act, the National Environmental Policy Act, the Toxic Substances Control Act, the Resource Conservation and Recovery Act, national restrictions, and other current and potential future local, state, federal, and foreign regulations.lessless

                  Key People

                  Dr. Leonard S. Schleifer,M.D.,PhD

                  CEO/Director/Founder/President

                  Dr. P. Roy Vagelos,M.D.

                  Chairman of the Board/Director

                  Dr. Alfred G Gilman M.D.,PhD

                  Co-Founder/Director

                  Robert E. Landry

                  CFO/Senior VP, Divisional

                  Douglas S. McCorkle,C.P.A.

                  Assistant Treasurer/Chief Accounting Officer/Controller/Vice President

                  • Regeneron Pharmaceuticals Inc

                  • 777 Old Saw Mill River Road

                  • Tarrytown, NY 10591-6707

                  • USA.Map

                  • Phone: +1 914 847-7000

                  • Fax: -

                  • regeneron.com

                  Incorporated

                  1988

                  Employees

                  2,340

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: